Novo Nordisk Strikes $2B Deal for Obesity Drug
Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by ...
FoneArena1mon
Indian tablet market up 25% YoY in 2024: CMR
The Indian tablet market saw a significant 25% year-on-year (YoY) growth in 2024, as per CyberMedia Research (CMR)’s Tablet PC India Market Report Review for CY2024. In Q4 2024, Samsung led the market ...